LYN NHOUNG: Open Payments
NPI 1689949729 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,115 in 106 payments from 17 companies in 2025. Trend: 2023 $2,377 · 2024 $2,678 · 2025 $2,115
Food & beverage: $2,115
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $359 |
| ABBVIE INC. | 24 | $333 |
| Ipsen Biopharmaceuticals, Inc | 5 | $234 |
| Ardelyx, Inc. | 9 | $222 |
| PFIZER INC. | 14 | $202 |
| Madrigal Pharmaceuticals | 10 | $169 |
| Gilead Sciences, Inc. | 8 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $120 |
| Lilly USA, LLC | 6 | $115 |
| Phathom Pharmaceuticals, Inc. | 2 | $41 |
Products named: TREMFYA, IQIRVO, IBSRELA, RINVOQ, REZDIFFRA, OMVOH, VELSIPITY, XELJANZ.
Industry payments across AZ — which companies pay providers there.
